Both in Pharmaceuticals
Enveric Biosciences vs Lexaria Bioscience
Over the past year ENVB returned −81.6% and LEXX returned −78.8%; their daily moves had a correlation of 0.01.
ENVB −81.6% LEXX −78.8%Growth of $1, one year, split-adjusted
| Metric | ENVB | LEXX |
|---|---|---|
| Price | $1.45 | $3.13 |
| Market cap | $6.5M | $6.6M |
| Today | −1.36% | −2.95% |
| 1 month | +5.8% | −69.8% |
| 6 months | −19.0% | −73.2% |
| Year to date | −60.1% | −66.2% |
| 1 year | −80.1% | −80.1% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 34.0× |
| Net cash | $8.3M | $3.6M |
| Dividend yield | — | — |
| Volatility (60d) | 55.3% | 838.1% |
| Short % of float | 0.6% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).